Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.04
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2004 | 2005 | 2006 | 2007 | |
|---|---|---|---|---|
| Revenue | $339.1K | $277.8K | $300.9K | $466.0K |
| Cost of revenue | $229.7K | $511.0K | $1.5M | $568.9K |
| Gross profit | $109.4K | −$233.1K | −$1.2M | −$103.0K |
| Gross margin | 32.3% | -83.9% | -403.7% | -22.1% |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | $4.4M | $6.2M | $4.9M | $1.4M |
| EBITDA | −$5.4M | −$5.7M | −$3.4M | −$1.2M |
| Net income | −$5.8M | −$7.0M | −$7.4M | −$2.9M |
| Net margin | -1708.6% | -2518.1% | -2445.0% | -621.9% |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
OPTIGENEX INC
No one on the platform currently holds OPGX.
No tracked institution reports a position in OPGX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2012-09-04 | 1-for-1200reverse |
No one on the platform has traded OPGX yet.
| $76658 |
| — |
| IMMBImmunotech Laboratories, Inc. | $0.00 | +0.00% | $114993 | — |
| INSDInstadose Pharma Corp. | $0.00 | +0.00% | $53193 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.